Maternal plasma vascular endothelial growth factor concentrations in normal and hypertensive pregnancies and their relationship to peripheral vascular resistance
Pm. Bosio et al., Maternal plasma vascular endothelial growth factor concentrations in normal and hypertensive pregnancies and their relationship to peripheral vascular resistance, AM J OBST G, 184(2), 2001, pp. 146-152
OBJECTIVE: The aim of this study was to measure maternal plasma vascular en
dothelial growth factor concentrations during normal and hypertensive pregn
ancies and examine their relationship with maternal total peripheral resist
ance values.
STUDY DESIGN: Plasma concentrations of total immunoreactive Vascular endoth
elial growth factor and total peripheral resistances were measured serially
throughout pregnancy in 20 women with preeclampsia, 24 women with gestatio
nal hypertension, and 26 normotensive control women. One-way analysis of va
riance and a regression model were used to analyze the vascular endothelial
growth factor levers in the groups and the relationship between vascular e
ndothelial growth factor concentration and total peripheral resistance.
RESULTS: At 10 to 14 weeks' gestation plasma vascular endothelial growth fa
ctor concentrations in all subjects were 4 to 5 times greater than the leve
ls measured post partum (P < .0001). Mean Vascular endothelial growth facto
r concentrations were similar in the control and gestational hypertension g
roups; in both groups levels remained stable until 34 to 36 weeks' gestatio
n, when levels increased a further 1.3-fold (P < .01). in comparison, vascu
lar endothelial growth factor concentrations in subjects in the preeclampsi
a group were greater at 28 to 32 weeks' gestation (P = .002) and at 34 to 3
6 weeks' gestation (P < .001). Vascular endothelial growth factor concentra
tions were also increased during the 4 weeks that preceded the diagnosis of
preeclampsia (P < .05). Vascular endothelial growth factor concentrations
were associated with the elevated total peripheral resistance observed duri
ng the clinical disorder in the preeclampsia group but not in the other gro
ups.
CONCLUSION: Maternal plasma vascular endothelial growth factor concentratio
ns increased before the clinical onset of preeclampsia and were further ele
vated during the vasoconstricted slate observed in this disorder. We specul
ate that the hyperdynamic circulation that characterizes the latent phase o
f preeclampsia causes vascular shear stress, which in turn increases the le
vels of circulating vascular endothelial growth factor. Because vascular en
dothelial growth factor normally acts as a vasodilator, its increase may re
present an unsuccessful vascular rescue response.